Neoadjuvant chemotherapy for unresectable carcinoma gall bladder: our experience

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter S. Bhoriwal
Citation Annals of Oncology (2016) 27 (2): 86-101. 10.1093/annonc/mdw201
Authors S. Bhoriwal1, M. Sultania2, S. Kumar2, S..V..S. Deo2, N. Shukla2, D. Pandey2, A. Sharma2, R. Sahoo2, S. Pathy2, S. Thulkar2, M. Pathak2
  • 1All India Institute of Medical Science, New Delhi, India, /
  • 2AIIMS, Delhi, India, /

Abstract

Gall bladder carcinoma is an aggressive malignancy. Around 10% of patients presenting in early stages are amenable to surgical resection. Most patients presents in advanced unresectable stage. Adjuvant chemoradiation is an effective adjuvant treatment for node positive completely resected carcinoma gall bladder however role of neoadjuvant chemotherapy in locally advanced stage, to make it surgically amenable, is less clear. Neoadjuvant chemotherapy can be an option in these patients to make their disease resectable.